Longeveron is a life sciences company developing biological solutions for aging and aging-associated diseases through the testing of allogeneic human Mesenchymal Stem Cells (MSCs) that are derived from the bone marrow of young, healthy donors The Longeveron-grown Mesenchymal Stem Cell (LMSCs) product is manufactured in Longeveron’s cell processing facility located in Miami, Florida.
Stem cell therapy is emerging as a promising new treatment option for chronic diseases and injuries affecting various organ systems. One of the most exciting ideas emerging from the field of regenerative medicine is the theory that stem cells can treat aging-related disability and frailty, reducing inflammation and improving functional capacity and quality of life for human beings. Stem cells have the potential to increase longevity and could ameliorate diseases and disorders associated with aging.
Currently there are no FDA-approved allogeneic mesenchymal stem cell treatments in the United States. Our LMSCs are currently undergoing rigorous testing for safety and efficacy in Phase I and II clinical trials. We hope to be the first to offer stem cells as a safe, effective, FDA-approved treatment for some of the world’s most difficult chronic and life-threatening conditions such as Aging Frailty, Alzheimer’s disease and the Metabolic Syndrome.
Longeveron is located in the Life Science & Technology Park (LSTP) in Miami, Florida. Its state-of-the-art manufacturing facilities and cell production are under US FDA oversight and comply with US FDA requirements. Thus, patients and physicians can be confident that a high-quality product is being used in our various clinical research initiatives throughout the world.